1 / 11

DASA 2006 and 4Q06 Earnings

DASA 2006 and 4Q06 Earnings. Disclaimer.

tarika
Télécharger la présentation

DASA 2006 and 4Q06 Earnings

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. DASA2006 and 4Q06Earnings

  2. Disclaimer This document contains “forward-looking statements”. Forward-looking statements may be identified by words such as “expects”. “intends”. “plans”. “believes”. “seeks”. “estimates” or words with similar meaning. The statements contained in this presentation about the Company’s forward-looking statements. including business prospects. operating and financial projections and potential growth are merely forecasts based on management’s expectations in relation to its future performance. Such estimates are highly dependent on market behavior. on Brazil’s economic performance and on industry and international market conditions. As such. they are subject to change.

  3. FY 2006 and 4th Quarter 2006 Financial Highlights 4Q06 R$ million 4Q05 2006 2005 Change Change 729.7 576.9 190.0 147.8 + 28.5% + 26.5% Gross Revenues 670.5 175.4 + 33.0% + 26.9% 528.3 131.9 Net Revenues 227.0 33.9% 36.3 27.5% 165.9 31.4% 52.1 29.7% +43.6% +36.8% Gross Profit Gross Margin 137.4 20.5% 119.0 22.5% 35.2 20.0% 24.3 18.4% +15.4% EBITDA +44.9% EBITDA Margin 135.9 30.7 167.8 25.0% 39.2 22.4% + 23.5% Adjusted EBITDA + 27.8% Adjusted EBITDA Margin 25.7% 23.3% 16.5 2.5% 1.7 10.2 1.9% +62.6% N.A. Net Earnings / Losses (7.6) 1.1% -5.7% Net Earnings / Losses Margin 266.0 +76.6% 469.7 266.0 +76.6% 469.7 Shareholder’s Equity - 63.7% (148.0) (53.8) (53.8) (148.0) -63.7% Net Cash/Debt

  4. Gross Revenues • Revenues increased 28.5% in the 4Q06, favored by: growth in imaging services. performance of the companies acquired during 2005 and strong growth in reference lab operations. In a yearly basis. the growth was 26.5% and overcame the last 4 years average CAGR; • The 5.9% decrease in the average revenue per requisition in the 4Q06 is a result of the mix of companies acquired during 2006 and also lower prices charged by Alvaro (only clinical). The decrease observed in the annual figures comes from mix improvements from imaging services that sustained average revenue per requisition practically flat (0.45% decrease); • Although 2006 same-unit-sales growth was 5.6%. After the negative effects experienced in 2Q06, when holidays and the World Cup affected the flow of patients in patient service centersthe recovery of patient flows during the 2H06 pulled the rate back to its historic average (6.8% in 4Q05). Gross Revenues Evolution (in R$ million) Growth Drivers (excluding Reference) 26.5% 729.7 112.2 CAGR = 21.2% 110.4 109.9 102.5 60.4 105.6 102.0 5.2 6.1 97.4 576.9 4.6 28.5% 3.9 491.4 3.3 399.8 323.8 1.6 190.0 1.3 147.8 16.3* 2002 2003 2004 2005 2006 4Q05 4Q06 2002 2003 2004 2005 2006 4Q05 4Q06 Requisitions Average Revenue per Requisition * Alvaro Reference Lab Revenues

  5. Gross Revenues per Service Line • Clinical Analysis revenues went up by 17.2%, mainly driven by the maturity of acquisitions settled in 2005 and new labs acquired during 2006; • Revenues from imaging services grew 18.0% quarter over quarter reaching 37.8% of Outpatient & Inpatient gross revenues. Image Memorial (Oct.’ 05) and Vita (Oct.’06) acquisitions as well as 7 new mega units opened in 2005 and 2006 helped to boost imaging revenues; • DASA’s national presence combined with Alvaro’s price competitiveness. helped lab to lab operations to increase the number of labs served and to offer more tests per lab. leveraging revenues by 43.8% in the 4Q06 (49.0% in 2006). Revenues per Service Line (as a % of Gross Revenues) Revenues - Reference (Lab to Lab) Market 28.5% 190.0 60.4 49.7% 37.8% 65.7 147.8 18.0% 40.5 37.7% 43.8% 55.7 27.2 62.2% 108.0 17.2% 18.0 16.3 62.3% 11.4 92.1 16.3* 4Q05 4Q06 2003 2004 2005 2006 4Q05 4Q06 * Alvaro Reference Lab Revenues

  6. 64.8% 0.7 1.3 3.9 0.4 61.0% 4Q06 Cash Personnel Materials Services and General COGs Utilities Expenses COGs Gross Profit • Gross margin improved 220 bps. to 29.7% in the 4Q06 from 27.5% in the 4Q05. This reflects not only scale gains in the central labs and PSCs. but also synergies from the integration of acquisitions done during 2005. In 2006 gross margin went up to 33.9%. 250 bps over 2005; • Reference Lab operations favored services and utilities dilution by 3.9 p.p. as a result of its fast growing pace, but affected material costs because of its differentiated cost structure; • Personnel costs went up on a yearly basis due to productivity gains yet to be captured from acquired companies. Cost of Services Rendered Cash-GOGS Drivers (4Q05 vs. 4Q06) 4Q05 Cash

  7. Operating Expenses • Operating expenses grew by 5.2% in the 4Q06 reaching R$ 45.6 million, mainly driven by SG&A higher expenses. This increase was offset by lower goodwill and financial expenses; • Parent Company G&A remained stable after the improvements on the management team, quality and IT were implemented. Consolidated G&A increases came mainly from the new acquired subsidiaries; • In 2006 the 31.4% growth reflects capital market related expenses, accrued as non recurring expenses. Operating Expenses (R$ million) General and Administrative Expenses (R$ million)

  8. EBITDA and Adjusted EBITDA • The strong 44.9% EBITDA growth in 4Q06 was leveraged by higher revenues. dilution of costs and reduction of operating expenses. Adjusted EBITDA grew 27.8% to R$ 39.2 million in 4Q06. with 22.4% margin; • On a yearly basis. Adjusted Ebitda reached R$ 167.8 million and outperformed the 2002 – 2005 4 year CAGR. by growing 23.5%. EBITDA and Adjusted EBITDA (R$ million) 23.5% 23.5% 167.8 167.8 30.4 30.4 EBITDA EBITDA 135.9 135.9 CAGR = 19.1% CAGR = 19.1% 123.1 123.1 Non Recurring Expenses 16.9 16.9 Adjusted EBITDA 99.4 99.4 38.5 38.5 15.3 15.3 80.4 80.4 27.7% 27.7% 15.5 15.5 137.4 137.4 119.0 119.0 39.2 39.2 84.6 84.6 84.1 84.1 30.7 30.7 4.0 4.0 64.9 64.9 6.4 6.4 35.2 35.2 24.3 24.3 2004 2004 2005 2005 2006 2006 4T05 4T05 4T06 4T06 2002 2002 2003 2003 2002 2002 2002 2003 2003 2003 2004 2004 2004 2005 2005 2005 2006 2006 2006 4T05 4T05 4T05 4T06 4T06 4T06 EBITDA Margin 21.8% 21.8% 21.8% 23.1% 23.1% 23.1% 18.9% 18.9% 18.9% 22.5% 22.5% 22.5% 20.5% 20.5% 20.5% 18.4% 18.4% 18.4% 20.0% 20.0% 20.0% Adjusted EBITDA Margin 27.1% 27.1% 27.1% 27.3% 27.3% 27.3% 27.5% 27.5% 27.5% 25.7% 25.7% 25.7% 25.0% 25.0% 25.0% 23.3% 23.3% 23.3% 22.4% 22.4% 22.4%

  9. Indebtedness • The Company cash generation was mainly employed on organic growth during 2006; • The capital markets operations helped to finance DASA’s acquisition plans and net debt reduction. by 63.7% y-o-y; • DASA still have R$ 325.9 million in cash and cash equivalents to finance 2007 expansion plans. Net Debt (Cash) Evolution (R$ million) 178.6 202.5 100.2 2006 Net Debt 2005 Net Debt Acquisitions Capex Cash Flow Generated Follow on Debeture Program (129.9) (54.7) (53.8) (148.0)

  10. Growth Strategy Update • The R$ 129.9 million Capex invested in 2006 exceeded the R$ 85.0 million proposed initially. mainly due to additional needs from subsidiaries and also to accelerate the expansion plan for imaging services and opening of new PSCs planned for 2007; • The R$ 95.0 million proposed for 2007 will be mainly driven to finance 20 new PSC (8 Mega Units) and purchase of equipments to expand imaging services. Investments1 (R$ million) 129.9 22.0 95.0 71.0 65.0 42.6 107.9 35.6 30.0 40.0 21.7 10.0 1.4 9.5 1.0 32.6 28.6 26.1 20.7 2003 2004 2005 1T06 2T06 3T06 4T06 2006 2007E Parent Co. Subsidiaries Consolidated Note: 1 Exclude acquisitions

  11. www.diagnosticosdaamerica.com.br

More Related